Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference49 articles.
1. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800. https://doi.org/10.1093/cid/ciq243.
2. Byrd KK, Hou JG, Hazen R, Kirkham H, Suzuki S, Clay PG, et al. Antiretroviral adherence level necessary for HIV viral suppression using real-world data. J Acquir Immune Defic Syndr. 2019;82(3):245–51. https://doi.org/10.1097/QAI.0000000000002142.
3. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report. 2022;27(3). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed October 5, 2022.
4. Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care—United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67(4):113. https://doi.org/10.15585/mmwr.mm6704a2.
5. Gwadz M, Cleland CM, Freeman R, Wilton L, Collins LM, Hawkins RL, et al. Stopping, starting, and sustaining HIV antiretroviral therapy: A mixed-methods exploration among African American/Black and Latino long-term survivors of HIV in an urban context. BMC Public Health. 2021;21(1):419. https://doi.org/10.1186/s12889-021-10464-x.